Company: SHPH
Filing Date: 2025-02-13
Form Type: S-1
Source: 0001493152-25-006202
Chunk: 244

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-13
Form: S-1
Chunk 244
---
 Report on Form 8-K filed on October 17, 2024).                                                                                                                                                        |
| 10.64  |     | Placement Agency Agreement, dated as of October 29, 2024, by and among Shuttle Pharmaceuticals Holdings, Inc. and A.G.P./Alliance Global Partners and Boustead Securities, LLC, as placement agents (incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K dated October 31, 2024). |
| 10.65  |     | Sponsored Research Agreement, dated December 16, 2024, by and among Shuttle Pharmaceuticals Holdings, Inc., the Regents of the University of California and Dr. Robert Favell (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed December 19, 2024).                     |
| 14.1   |     | Code                                                                                                                                                                                                                                                                                                     
 of Business Conduct and Ethics (incorporated by reference to Exhibit 10.3 to the Registration Statement on Form S-1 (File No. 333-265429)                                                                                                                                                                
 filed on June 3, 2022).                                                                                                                                                                                                                                                                                  |
| 21     |     | List                                                                                                                                                                                                                                                                                                     
 of Subsidiaries (incorporated by reference to Exhibit 21 to the Annual Report on Form 10-K filed on March 21, 2024).                                                                                                                                                                                     |
| 23.1   |     | Consent of Forvis Mazars, LLP                                                                                                                                                                                                                                                                            |
| 23.2*  |     | Consent of Dorsey & Whitney LLP (included in Exhibit 5.1)                                                                                                                                                                                                                                                |
| 24     |     | Power of Attorney (included in the signature page to this registration statement).                                                                                                                                                                                                                       |
| 107    |     | Filing Fee Table                                                                                                                                                                                                                                                                                         |

*To be filed

◊Previously filed

+Certain portions of this exhibit have been redacted in accordance with Item 601(b)(10)(iv) because such information (i) is deemed not material and (ii) is of the type of information that the Company normally treats as private or confidential.

| II-5 |

| ITEM 
 17.  | UNDERTAKINGS |

The undersigned registrant hereby undertakes:

(a) (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required